Related by context. Frequent words. (Click for all words.) 62 coronary intervention 62 thromboprophylaxis 62 antithrombotic 61 Perindopril 60 voriconazole 60 Dasatinib 60 carotid artery stenting 60 ximelagatran 60 antiplatelet agents 60 calcineurin inhibitors 59 Losartan 59 acute coronary syndromes ACS 59 Natalizumab 59 mRCC 59 drug eluting stent DES 59 mycophenolate mofetil 59 oral anticoagulant 59 COPD exacerbations 59 mTOR inhibitor 59 antihypertensive therapy 59 direct thrombin inhibitor 58 coronary stenting 58 superficial bladder cancer 58 secondary hyperparathyroidism 58 Aliskiren 58 coronary revascularization 58 nephrotoxicity 58 glatiramer acetate 58 liposomal formulation 58 Oxaliplatin 58 fluvastatin 58 beta blocker therapy 58 pancreatic insufficiency 58 Lenalidomide 58 Combination therapy 58 olmesartan medoxomil 57 revascularization procedures 57 Cyclosporine 57 ADHF 57 paclitaxel eluting stents 57 lupus nephritis 57 acute coronary syndromes 57 Chronic Heart Failure 57 olmesartan 57 TYGACIL 57 thrombolytics 57 clopidogrel Plavix 57 gastrointestinal stromal tumors GIST 57 PRADAXA 57 phosphate binders 57 thrombotic events 57 arterial thrombosis 57 platelet reactivity 57 ASCT 57 eptifibatide 57 revascularisation 57 thromboembolic events 57 Tygacil 57 APTIVUS 57 Acute Myocardial Infarction 57 antiplatelet 56 forodesine 56 Acute Coronary Syndrome 56 Microplasmin 56 vertebral compression fractures 56 Irinotecan 56 intravesical 56 carotid stenting 56 platelet inhibition 56 Angiox 56 thromboembolism 56 TAXUS Stent 56 lipid lowering drugs 56 muraglitazar 56 antiplatelet therapy 56 Mipomersen 56 Panzem R 56 carotid stenosis 56 Percutaneous Coronary Intervention 56 Eltrombopag 56 oral anticoagulants 56 therapeutic regimens 56 deforolimus 56 Carotid 56 tecarfarin 56 cardiac dysfunction 56 ZD# [001] 56 TAXUS Liberte 56 corticosteroid therapy 56 atherothrombosis 56 irbesartan 56 Dapagliflozin 56 antiepileptic drug 56 NeuroStar TMS Therapy 56 thrombophilia 56 nonrandomized 55 Pirfenidone 55 multiple myeloma MM 55 patients undergoing percutaneous 55 colorectal carcinoma 55 efficacy tolerability